European Manufacturing Giant Selects Labvantage
News Apr 25, 2012
LABVANTAGE has announced that an European manufacturing giant has selected its LIMS solution to replace its existing LIMS to meet GLP-requirements at its R&D headquarters. The solution will manage next generation product testing, part of the research and development pipeline, for key functionality such as stability testing, chemistry, and physicochemical testing. LABVANTAGE provides a user-friendly, intuitive and configurable GUI, delivered entirely via thin-client web browser. The new LIMS will also manage the facility’s extensive library of study protocols while enabling better decision making through its advanced reporting and analytics. LABVANTAGE’s Advanced Storage and Logistics, CAPA (Corrective Actions, Preventive Actions) and Connect Advanced Instrument Interface will also be deployed.
“This project provides an out-of-the-box LIMS solution that fully fits into the customer’s existing product life-cycle management process and further validates our investment into this part of the customer enterprise. We remain confident that our substantial investments into our own product portfolio will continue to extend our competitive differentiation in this legacy replacement market,” says Jeff Ferguson, LABVANTAGE Chief Executive Officer.
The implementation will be deployed in three phases: analysis request, logistics, and chemistry assessment-related analyses in phase one; product development support, batch release support and stability for phase two; and in vitro testing for phase three.
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.
Towards Personalized Medicine: One Type of Data is Not EnoughNews
To understand the biology of diseased organs researchers use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types. A new computational method jointly analyses different types of molecular data and disentangles the sources of disease variability to guide personalized treatment.READ MORE